ARS Pharmaceuticals Inc
XNAS: SPRY
ARS Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart
about
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary co...
Read More
10.39
-0.31
(-2.90%)
1.1M
XNAS Volume
XNAS 09 Sep, 2025 1:27 PM (EDT)
Board Meeting
The next board meeting for ARS Pharmaceuticals Inc is on 15 Sep 2025 for the purpose of Stifel Immunology and Inflammation Summit
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
ARS Pharmaceuticals Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..